Skip to content

Language: Japanese

DarwinHealth Publication Reports Step-by-Step Protocol for its Tumor Checkpoint-Based, Compound-to-Clinic (C2C) Cancer Drug Discovery Pipeline: Elucidates a Patient-to-Model-to-Patient (PMP) Roadmap for Precision- and Mechanism-Based Identification and Clinical Validation of Novel, Investigational and FDA-Approved Therapeutic Agents Targeting Tumor Regulatory Architecture

By asianet

DarwinHealth, Inc., (www.DarwinHealth.com) a New York-based biotechnology and cancer drug discovery company announces the September 9, 2022 online publication in Current Protocols (Wiley Science) of their proprietary cancer drug discovery and validation pipeline, “A Patient-to-Model-to-Patient (PMP) cancer drug and biomarker discovery protocol for identifying and validating therapeutic agents targeting tumor regulatory architecture.” Logo – https://mma.prnewswire.com/media/966600/DarwinHealth_Logo.jpg … Continued

EpiVax Secures Additional Funding from FDA for Immunogenicity Risk Assessment for Biosimilar Products

By asianet

EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) for improving biosimilar product development and assessing product interchangeability (# U01FD007760). The research will commence … Continued

MASSIMO CALAFIORE APPOINTED AS NEW LIMACORPORATE CEO

By asianet

LimaCorporate, a leading global orthopedic manufacturer focused on digital innovation and patient-tailored devices, today announces that Massimo Calafiore has been appointed by the Board of Directors as the new Chief Executive Officer of the company. Massimo’s appointment follows a thorough selection process that considered both internal and external candidates. Emmanuel Bonhomme, who has led the organization … Continued

FDI WORLD DENTAL FEDERATION LAUNCHES TOOLKIT ON HOW TO MAKE DENTISTRY MORE SUSTAINABLE

By asianet

Dental practices can use the tools as a guide to make their work more environmentally sustainable and by tracking progress they can achieve recognition awards for their efforts. FDI World Dental Federation (FDI) today launched a Toolkit for Sustainable Dentistry[https://www.sustainability-platform.fdiworlddental.org/], to help dental practices understand what actions they can take to ensure their work is … Continued

Janngo Capital Startup Fund, Africa’s largest gender equal tech VC fund reaches the first close of its €60 million new fund

By asianet

At the eve of the 77th Session of the UN General Assembly (UNGA), Janngo Capital Startup Fund (JCSF) has announced its first close at EUR34 million (approximately US$36 million) in capital commitments. Launched in Davos in 2020, Janngo Capital’s latest fund will invest 50% of its proceeds in companies founded, co-founded, or benefiting women. Backed … Continued

LSLiDAR’s Image-grade 1550nm LiDAR ‘LS Series’ is Now Available for Automotive OEMs, Taking Vehicle Safety to a New Height!

By asianet

On August 13, 2022 (Shenzhen, China), LSLiDAR, the world’s leading 3D sensing solution provider, launched its new LS series 1550nm fiber laser automotive-grade LiDAR (hereafter referred to as LS series) at the China International Automotive Industry Annual Conference. LS series is designed to meet long-range and high-resolution sensing requirements in high-way ADAS L3+ applications. Equipped … Continued

Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment, to enter the Middle East and Egypt with NaoTrac Neurosurgical Robot

By asianet

Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq Medical Equipment, to expand the distribution of the Surgical Navigation Robot, NaoTrac, throughout the region of GCC region, Jordan, Egypt plus other countries in the Middle East and Philippines, Indonesia, Malaysia, and Singapore which will be covered by Medtreq … Continued

First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

By asianet

An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon. The PERFECT-SELUTION FIM (PElvic Revascularization For EreCTile dysfuction-SELUTION First-In-Man) study involves a total of 54 patients suffering from distal internal pudendal-penile artery stenotic disease and ED. … Continued